Latest Funding News

GWR is actively pursuing transformative project acquisitions across global jurisdictions while trading significantly below its cash and investment backing. The company’s robust cash position and critical minerals investments position it well amid shifting global supply dynamics.

Acorn Capital Investment Fund’s shares were suspended following a late submission of its January 2025 Net Tangible Asset Statement, attributed to human error. The company has assured shareholders the issue is resolved and trading resumed promptly.

HiTech Group has reported a robust first half for FY2025, with net profit before tax up 14% and EBITDA rising 8%, underpinned by strong demand for ICT talent and services. The company also declared a fully franked interim dividend of 5 cents per share, signaling confidence in its growth trajectory.

QMines Limited has raised $6 million through a strongly supported placement, positioning the company to accelerate exploration and development at its Mt Chalmers and Develin Creek copper and gold projects.

Future Metals NL has confirmed a significant copper-nickel mineralised intrusion extending 4.5km at its Eileen Bore Prospect, marking a major step forward in its exploration campaign.

Althea Group Holdings has raised $4 million through a share and loan note placement to boost its THC beverage production and infrastructure across North America, targeting rapid growth in the U.S. and Canada.

Variscan Mines reports strong progress in its maiden underground drilling at the Udias Mine, with assay results expected soon, while advancing critical studies for a mine restart at its Novales-Udias Project.

The Star Entertainment Group has received a $650 million debt refinancing proposal from Oaktree Capital Management, offering a potential boost to its liquidity but shadowed by significant conditions and uncertainty.

Winsome Resources has raised approximately A$7.8 million through a placement to advance its flagship Adina Lithium Project and extend the Renard Option to August 2025, with plans for an additional share purchase plan targeting A$2.5 million.

PYC Therapeutics has launched a A$145.8 million pro-rata accelerated non-renounceable entitlement offer to fund late-stage clinical trials across its pipeline targeting rare diseases with high unmet needs. The capital raise aims to extend the company’s cash runway beyond FY27, supporting four drug candidates through critical human safety and efficacy milestones.

Havilah Resources has completed a 7,511-metre drilling program at its Mutooroo copper-cobalt-gold project, revealing promising extensions beyond the current resource envelope. Collaborative efforts with JX Advanced Metals Corporation advance metallurgical and mining studies, underpinning a potential resource upgrade.

PYC Therapeutics is set to raise up to $146 million through a pro-rata entitlement offer, aiming to accelerate its RNA-based drug candidates targeting major unmet medical needs. Major shareholder support and underwriting commitments underpin the capital raise.